05.05.2020 - 05.03.2021

An open labeled randomized controlled pragmatic trial to evaluate the efficacy and safety of Montelukast as add on treatment to the novel coronavirus pneumonia.



Ref
no ref

Financing Instituitions
Support Research 4 Covid-19 - FCT

Participating Institutions
CHUSJ; FMUP.

Summary

 

Begin Date: 5th may 2020

End Date: 5th march 2021

 

Total Budget: 30.000,00 €

 

Principal Investigator: André Moreira

 

Summary available in Portuguese

 


Calendar

Weekly Publication

The neighbourhood natural environment is associated with asthma in children: a birth cohort study.
Allergy
Read More